arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Novartis AG

NVS Health Care Biotechnology: Pharmaceutical Preparations
$154.44
0.0% Today
as of Aug 5, 16:52 ET
Last 30 days -0.62% Jun 26 → Aug 05
$148.73 $151.73 $154.73 $157.73 $160.73 Jun 26 Jul 06 Jul 14 Jul 21 Jul 29 Aug 05
Open
$147.65
High
$149.16
Low
$147.44
Volume
$3M
Avg Vol
$2M
Mkt Cap
$297.9B
P/E (TTM)
—
Beta
—
52w High
$170.46
52w Low
$112.34
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

mixed ▲ 2 ● 23 ▼ 0
Aug 2 · 10:06 REGULATORY Simply Wall St. bullish
Novartis (SWX:NOVN) Wins FDA Approval For Pluvicto In Earlier Prostate Cancer
Jul 28 · 23:40 Morningstar Research neutral
Analyst Report: Novartis AG
Jul 27 · 11:12 Argus Research neutral
Analyst Report: Novartis AG
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$112
$170
72% of range
Avg surprise (last 2)
+4.6%
Avg reaction (last 2)
-1.3%
50% positive
Latest IV / EM
27%
EM ±4.5% · $155 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$2.12$2.20$2.27$2.34$2.42 Actual $2.28Est $2.12Actual $2.42Est $2.38 Mar/2025Jun/2025

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu Jul 17, 2025Jun/2025 $2.42 $2.38 +1.7% — -3.3% earnings
Tue Apr 29, 2025Mar/2025 $2.28 $2.12 +7.5% — +0.7% earnings

Implied volatility — last 90 days

22%26%30%33%37% Jun 07 — IV 25% · EM ±3.5%Jun 08 — IV 27% · EM ±3.6%Jun 09 — IV 26% · EM ±3.3%Jun 10 — IV 27% · EM ±3.2%Jun 11 — IV 25% · EM ±2.8%Jun 12 — IV 25% · EM ±2.6%Jun 15 — IV 28% · EM ±2.1%Jun 16 — IV 27% · EM ±1.6%Jun 17 — IV 30% · EM ±1.3%Jun 19 — IV 25% · EM ±5.5%Jun 22 — IV 23% · EM ±4.8%Jun 23 — IV 23% · EM ±4.7%Jun 24 — IV 24% · EM ±4.7%Jun 25 — IV 23% · EM ±4.5%Jun 26 — IV 24% · EM ±4.5%Jun 29 — IV 25% · EM ±4.4%Jun 30 — IV 25% · EM ±4.3%Jul 01 — IV 25% · EM ±4.2%Jul 02 — IV 26% · EM ±4.2%Jul 03 — IV 27% · EM ±4.2%Jul 06 — IV 26% · EM ±3.7%Jul 07 — IV 29% · EM ±3.8%Jul 08 — IV 26% · EM ±3.3%Jul 09 — IV 24% · EM ±2.8%Jul 10 — IV 24% · EM ±2.6%Jul 13 — IV 29% · EM ±2.5%Jul 14 — IV 28% · EM ±2.0%Jul 15 — IV 30% · EM ±1.8%Jul 16 — IV 38% · EM ±1.6%Jul 20 — IV 29% · EM ±6.8%Jul 21 — IV 28% · EM ±6.6%Jul 22 — IV 26% · EM ±5.9%Jul 23 — IV 25% · EM ±5.6%Jul 24 — IV 24% · EM ±5.4%Jul 27 — IV 25% · EM ±5.3%Jul 28 — IV 26% · EM ±5.4%Jul 29 — IV 29% · EM ±5.7%Jul 30 — IV 27% · EM ±5.2%Jul 31 — IV 27% · EM ±5.1%Aug 03 — IV 29% · EM ±5.1%Aug 04 — IV 28% · EM ±4.9%Aug 05 — IV 27% · EM ±4.5%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,164.75-0.4%
JNJ
Johnson & Johnson
$624.1B $258.23+0.2%
ABBV
AbbVie Inc.
$454.8B $246.35+0.1%
MRK
Merck & Company, Inc.
$321.6B $129.20+0.7%
PM
Philip Morris International Inc
$299.3B $188.93-0.0%
AZN
AstraZeneca PLC
$272.3B $161.40-0.1%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in